Apeiron Ria LLC Abb Vie Inc. Transaction History

Apeiron Ria LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$159.82 - $182.1 $890,517 - $1.01 Million	-5,572 Reduced 6.51%	80,008 $14.6 Million
Q4 2022 Jan 20, 2023	SELL	$138.31 - $165.87 $138 - $165	-1 Reduced -0.0%	85,580 $0
Q3 2022 Oct 18, 2022	SELL	$134.21 - $153.93 $671,050 - $769,650	-5,000 Reduced 5.52%	85,581 $11.5 Million
Q2 2022 Jul 26, 2022	BUY	$137.62 - $174.96 $9,495 - $12,072	69 Added 0.08%	90,581 $139 Million
Q4 2021 Feb 15, 2022	BUY	$107.43 - $135.93 $9.72 Million - $12.3 Million	90,512 New	90,512 $12.3 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Apeiron Ria LLC, based on Form 13F filings with the SEC.

Stay updated on Apeiron Ria LLC with notifications on news.